These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19496610)

  • 21. Delineating common molecular mechanisms in Alzheimer's and prion diseases.
    Barnham KJ; Cappai R; Beyreuther K; Masters CL; Hill AF
    Trends Biochem Sci; 2006 Aug; 31(8):465-72. PubMed ID: 16820299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
    Faller P; Hureau C
    Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the oxygen-based ligand of the low pH component of the Cu(2+)-amyloid-β complex.
    Gomez-Castro CZ; Vela A; Quintanar L; Grande-Aztatzi R; Mineva T; Goursot A
    J Phys Chem B; 2014 Aug; 118(34):10052-64. PubMed ID: 25090035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of the Zn2+ binding in the 1-16 region of the amyloid beta peptide involved in Alzheimer's disease.
    Furlan S; La Penna G
    Phys Chem Chem Phys; 2009 Aug; 11(30):6468-81. PubMed ID: 19809679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.
    Streltsov VA; Varghese JN
    Chem Commun (Camb); 2008 Jul; (27):3169-71. PubMed ID: 18594731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
    Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
    Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry.
    Haeffner F; Smith DG; Barnham KJ; Bush AI
    J Inorg Biochem; 2005 Dec; 99(12):2403-22. PubMed ID: 16271394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper catalyzed oxidation of Alzheimer Abeta.
    Atwood CS; Huang X; Khatri A; Scarpa RC; Kim YS; Moir RD; Tanzi RE; Roher AE; Bush AI
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):777-83. PubMed ID: 10875439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-field and ligand-binding analysis of the active site of copper-bound Aβ associated with Alzheimer's disease.
    Ghosh C; Dey SG
    Inorg Chem; 2013 Feb; 52(3):1318-27. PubMed ID: 23330670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct evidence that all three histidine residues coordinate to Cu(II) in amyloid-beta1-16.
    Shin BK; Saxena S
    Biochemistry; 2008 Sep; 47(35):9117-23. PubMed ID: 18690709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying, by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer's disease.
    La Penna G; Hureau C; Andreussi O; Faller P
    J Phys Chem B; 2013 Dec; 117(51):16455-67. PubMed ID: 24313818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
    Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
    Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.
    Karr JW; Szalai VA
    J Am Chem Soc; 2007 Apr; 129(13):3796-7. PubMed ID: 17352478
    [No Abstract]   [Full Text] [Related]  

  • 36. New insights into the coordination of Cu(II) by the amyloid-B 16 peptide from Fourier transform IR spectroscopy and isotopic labeling.
    El Khoury Y; Dorlet P; Faller P; Hellwig P
    J Phys Chem B; 2011 Dec; 115(49):14812-21. PubMed ID: 22026330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the ZnII binding to the peptide amyloid-beta1-16 linked to Alzheimer's disease.
    Mekmouche Y; Coppel Y; Hochgräfe K; Guilloreau L; Talmard C; Mazarguil H; Faller P
    Chembiochem; 2005 Sep; 6(9):1663-71. PubMed ID: 16078307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
    Danielsson J; Pierattelli R; Banci L; Gräslund A
    FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A direct determination of the dissociation constant for the Cu(II) complex of amyloid beta 1-40 peptide.
    Rózga M; Kłoniecki M; Dadlez M; Bal W
    Chem Res Toxicol; 2010 Feb; 23(2):336-40. PubMed ID: 19911803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity.
    Meloni G; Sonois V; Delaine T; Guilloreau L; Gillet A; Teissié J; Faller P; Vasák M
    Nat Chem Biol; 2008 Jun; 4(6):366-72. PubMed ID: 18454142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.